576 related articles for article (PubMed ID: 33262250)
1. Predicting Drug Interactions with Human Equilibrative Nucleoside Transporters 1 and 2 Using Functional Knockout Cell Lines and Bayesian Modeling.
Miller SR; Zhang X; Hau RK; Jilek JL; Jennings EQ; Galligan JJ; Foil DH; Zorn KM; Ekins S; Wright SH; Cherrington NJ
Mol Pharmacol; 2021 Feb; 99(2):147-162. PubMed ID: 33262250
[TBL] [Abstract][Full Text] [Related]
2. Nucleoside Reverse Transcriptase Inhibitor Interaction with Human Equilibrative Nucleoside Transporters 1 and 2.
Miller SR; Hau RK; Jilek JL; Morales MN; Wright SH; Cherrington NJ
Drug Metab Dispos; 2020 Jul; 48(7):603-612. PubMed ID: 32393653
[TBL] [Abstract][Full Text] [Related]
3. Remdesivir and EIDD-1931 Interact with Human Equilibrative Nucleoside Transporters 1 and 2: Implications for Reaching SARS-CoV-2 Viral Sanctuary Sites.
Miller SR; McGrath ME; Zorn KM; Ekins S; Wright SH; Cherrington NJ
Mol Pharmacol; 2021 Dec; 100(6):548-557. PubMed ID: 34503974
[TBL] [Abstract][Full Text] [Related]
4. Multiple Computational Approaches for Predicting Drug Interactions with Human Equilibrative Nucleoside Transporter 1.
Miller SR; Lane TR; Zorn KM; Ekins S; Wright SH; Cherrington NJ
Drug Metab Dispos; 2021 Jul; 49(7):479-489. PubMed ID: 33980604
[TBL] [Abstract][Full Text] [Related]
5. Basolateral uptake of nucleosides by Sertoli cells is mediated primarily by equilibrative nucleoside transporter 1.
Klein DM; Evans KK; Hardwick RN; Dantzler WH; Wright SH; Cherrington NJ
J Pharmacol Exp Ther; 2013 Jul; 346(1):121-9. PubMed ID: 23639800
[TBL] [Abstract][Full Text] [Related]
6. Fluorouracil uptake in triple-negative breast cancer cells: Negligible contribution of equilibrative nucleoside transporters 1 and 2.
Noguchi S; Takagi A; Tanaka T; Takahashi Y; Pan X; Kibayashi Y; Mizokami R; Nishimura T; Tomi M
Biopharm Drug Dispos; 2021 Mar; 42(2-3):85-93. PubMed ID: 33426680
[TBL] [Abstract][Full Text] [Related]
7. Interaction of a series of draflazine analogues with equilibrative nucleoside transporters: species differences and transporter subtype selectivity.
Hammond JR
Naunyn Schmiedebergs Arch Pharmacol; 2000 Apr; 361(4):373-82. PubMed ID: 10763851
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of human equilibrative nucleoside transporters by 4-((4-(2-fluorophenyl)piperazin-1-yl)methyl)-6-imino-N-(naphthalen-2-yl)-1,3,5-triazin-2-amine.
Tang PCT; Yang C; Li RW; Lee SM; Hoi MP; Chan SW; Kwan YW; Tse CM; Leung GP
Eur J Pharmacol; 2016 Nov; 791():544-551. PubMed ID: 27388143
[TBL] [Abstract][Full Text] [Related]
9. Testicular disposition of clofarabine in rats is dependent on equilibrative nucleoside transporters.
Miller SR; Jilek JL; McGrath ME; Hau RK; Jennings EQ; Galligan JJ; Wright SH; Cherrington NJ
Pharmacol Res Perspect; 2021 Aug; 9(4):e00831. PubMed ID: 34288585
[TBL] [Abstract][Full Text] [Related]
10. Dilazep analogues for the study of equilibrative nucleoside transporters 1 and 2 (ENT1 and ENT2).
Playa H; Lewis TA; Ting A; Suh BC; Muñoz B; Matuza R; Passer BJ; Schreiber SL; Buolamwini JK
Bioorg Med Chem Lett; 2014 Dec; 24(24):5801-5804. PubMed ID: 25454272
[TBL] [Abstract][Full Text] [Related]
11. Contribution of equilibrative nucleoside transporter(s) to intestinal basolateral and apical transports of anticancer trifluridine.
Takahashi K; Yoshisue K; Chiba M; Nakanishi T; Tamai I
Biopharm Drug Dispos; 2018 Jan; 39(1):38-46. PubMed ID: 29055025
[TBL] [Abstract][Full Text] [Related]
12. Functional expression of equilibrative and concentrative nucleoside transporters in alveolar epithelial cells.
Baba S; Yumoto R; Kawami M; Takano M
Pharmazie; 2021 Sep; 76(9):416-421. PubMed ID: 34481531
[TBL] [Abstract][Full Text] [Related]
13. Differential Inhibition of Equilibrative Nucleoside Transporter 1 (ENT1) Activity by Tyrosine Kinase Inhibitors.
Jouan E; Moreau A; Bruyere A; Alim K; Denizot C; Parmentier Y; Fardel O
Eur J Drug Metab Pharmacokinet; 2021 Sep; 46(5):625-635. PubMed ID: 34275128
[TBL] [Abstract][Full Text] [Related]
14. Quantification of ENT1 and ENT2 Proteins at the Placental Barrier and Contribution of These Transporters to Ribavirin Uptake.
Nishimura T; Sano Y; Takahashi Y; Noguchi S; Uchida Y; Takagi A; Tanaka T; Katakura S; Nakashima E; Tachikawa M; Maruyama T; Terasaki T; Tomi M
J Pharm Sci; 2019 Dec; 108(12):3917-3922. PubMed ID: 31520644
[TBL] [Abstract][Full Text] [Related]
15. Cloning of the human equilibrative, nitrobenzylmercaptopurine riboside (NBMPR)-insensitive nucleoside transporter ei by functional expression in a transport-deficient cell line.
Crawford CR; Patel DH; Naeve C; Belt JA
J Biol Chem; 1998 Feb; 273(9):5288-93. PubMed ID: 9478986
[TBL] [Abstract][Full Text] [Related]
16. Kinetic and pharmacological properties of cloned human equilibrative nucleoside transporters, ENT1 and ENT2, stably expressed in nucleoside transporter-deficient PK15 cells. Ent2 exhibits a low affinity for guanosine and cytidine but a high affinity for inosine.
Ward JL; Sherali A; Mo ZP; Tse CM
J Biol Chem; 2000 Mar; 275(12):8375-81. PubMed ID: 10722669
[TBL] [Abstract][Full Text] [Related]
17. Equilibrative Nucleoside Transporter 1 (ENT1,
Cerveny L; Ptackova Z; Ceckova M; Karahoda R; Karbanova S; Jiraskova L; Greenwood SL; Glazier JD; Staud F
Drug Metab Dispos; 2018 Nov; 46(11):1817-1826. PubMed ID: 30097436
[TBL] [Abstract][Full Text] [Related]
18. Crosstalk between the equilibrative nucleoside transporter ENT2 and alveolar Adora2b adenosine receptors dampens acute lung injury.
Eckle T; Hughes K; Ehrentraut H; Brodsky KS; Rosenberger P; Choi DS; Ravid K; Weng T; Xia Y; Blackburn MR; Eltzschig HK
FASEB J; 2013 Aug; 27(8):3078-89. PubMed ID: 23603835
[TBL] [Abstract][Full Text] [Related]
19. Subtype-specific regulation of equilibrative nucleoside transporters by protein kinase CK2.
Stolk M; Cooper E; Vilk G; Litchfield DW; Hammond JR
Biochem J; 2005 Mar; 386(Pt 2):281-9. PubMed ID: 15500446
[TBL] [Abstract][Full Text] [Related]
20. Targeting the Plasmodium vivax equilibrative nucleoside transporter 1 (PvENT1) for antimalarial drug development.
Deniskin R; Frame IJ; Sosa Y; Akabas MH
Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):1-11. PubMed ID: 26862473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
